Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.32 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.32 |
| ▸ | HRH2 | P25021 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 4/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.31 |
| ▸ | JAK1 | P23458 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | HTR2B | P41595 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30299316 | 0.90 | ALDH1A1 (0.36) | ALDH1A1OPRD1GRIN2B | |
| SCHEMBL30299380 | 0.83 | PRKCQ (0.31) | — | |
| SCHEMBL30299400 | 0.80 | LTA4H (0.47) | ALDH1A1OPRD1HRH1HRH3HTR2A | |
| SCHEMBL30299386 | 0.79 | SIGMAR1 (0.40) | ALDH1A1OPRD1HRH1HRH3HTR2A | |
| SCHEMBL30299348 | 0.79 | GPR4 (0.42) | ALDH1A1HRH3 | |
| SCHEMBL30299272 | 0.79 | LTA4H (0.46) | ALDH1A1OPRD1HRH1HRH3HTR2A | |
| SCHEMBL30299399 | 0.79 | GPR4 (0.37) | ALDH1A1SIGMAR1 | |
| SCHEMBL30299358 | 0.78 | GPR4 (0.43) | ALDH1A1HRH3 | |
| SCHEMBL30299395 | 0.77 | TSHR (0.38) | ALDH1A1OPRD1HRH1HTR2AHTR2B | |
| SCHEMBL30299394 | 0.77 | GPR4 (0.43) | ALDH1A1OPRD1HRH1HRH3HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115916344-A | AXL inhibitors for antiviral therapy | 卑尔根生物股份公司 | 2023-04-04 | — | — | CN | disclosed |